Free Trial

Evotec (EVTCY) Financials

Evotec logo
$4.73 +0.70 (+17.37%)
As of 05/23/2025
Annual Income Statements for Evotec

Annual Income Statements for Evotec

This table shows Evotec's income and expenses over time, based on annual financial data. All values are USD millions unless otherwise specified.

Metric 2024 2023 2022 2021 2020 2019
Period end date 12/31/2024 12/31/2023 12/31/2022 12/31/2021 12/31/2020 12/31/2019
Net Income / (Loss) Attributable to Common Shareholders
-203 -93 -188 244 29 54
Consolidated Net Income / (Loss)
-203 -93 -188 244 7.67 42
Net Income / (Loss) Continuing Operations
-203 -93 -188 244 29 54
Total Pre-Tax Income
-201 -89 -165 268 53 75
Total Operating Income
-91 -53 22 46 -25 -2.10
Total Gross Profit
119 194 186 172 154 149
Total Revenue
825 864 804 699 612 501
Operating Revenue
825 864 804 699 612 501
Total Cost of Revenue
706 671 618 528 458 352
Operating Cost of Revenue
706 671 618 528 458 352
Total Operating Expenses
210 246 164 125 178 151
Selling, General & Admin Expense
195 188 167 119 94 75
Research & Development Expense
53 76 82 82 78 66
Other Operating Expenses / (Income)
-38 -23 -85 -77 6.07 11
Impairment Charge
0.00 5.54 0.00 0.77 - -
Total Other Income / (Expense), net
-110 -37 -187 222 78 77
Interest & Investment Income
-44 -33 -200 221 - -
Other Income / (Expense), net
-66 -3.53 13 0.91 88 86
Income Tax Expense
2.18 3.67 23 24 24 22
Weighted Average Basic Shares Outstanding
177.55M 177.19M 176.67M 166.41M 153.75M 149.73M
Diluted Earnings per Share
($2.30) ($1.04) ($2.12) $2.94 - -
Weighted Average Diluted Shares Outstanding
177.55M 177.19M 176.67M 166.41M 153.75M 149.73M
Weighted Average Basic & Diluted Shares Outstanding
177.30M 176.92M 176.67M 166.41M 153.75M 149.73M

Quarterly Income Statements for Evotec

No quarterly income statements for Evotec are available.


Annual Cash Flow Statements for Evotec

This table details how cash moves in and out of Evotec's business through operations, investing, and financing, using annual figures. All values are USD millions unless otherwise specified.

Metric 2024 2023 2022 2021 2020 2019
Period end date 12/31/2024 12/31/2023 12/31/2022 12/31/2021 12/31/2020 12/31/2019
Net Change in Cash & Equivalents
-135 375 -284 313 166 187
Net Cash From Operating Activities
-27 -29 -161 -27 175 47
Net Cash From Continuing Operating Activities
-27 -29 -161 -27 175 49
Net Income / (Loss) Continuing Operations
-203 -93 -188 244 7.67 42
Consolidated Net Income / (Loss)
-203 -93 -188 244 7.67 42
Depreciation Expense
105 103 89 80 51 41
Non-Cash Adjustments To Reconcile Net Income
71 -40 -198 -354 89 18
Net Cash From Investing Activities
24 286 -64 -136 -28 -97
Net Cash From Continuing Investing Activities
24 286 -64 -136 -28 -81
Purchase of Property, Plant & Equipment
-15 -2.96 -194 -135 - -36
Sale of Property, Plant & Equipment
2.07 0.59 0.00 0.00 - -
Sale and/or Maturity of Investments
37 288 219 31 - -
Net Cash From Financing Activities
-132 119 -62 445 18 237
Net Cash From Continuing Financing Activities
-132 119 -36 474 18 237
Repayment of Debt
-133 -125 -36 -18 -7.96 -93
Issuance of Debt
0.93 243 0.38 491 26 328
Cash Interest Paid
6.13 14 6.13 6.14 - -
Cash Interest Received
5.85 11 3.24 1.20 - -

Quarterly Cash Flow Statements for Evotec

No quarterly cash flow statements for Evotec are available.


Annual Balance Sheets for Evotec

This table presents Evotec's assets and liabilities at the end of each period, using annual balance sheet data. All values are USD millions unless otherwise specified.

Metric 2024 2023 2022 2021 2020
Period end date 12/31/2024 12/31/2023 12/31/2022 12/31/2021 12/31/2020
Total Assets
1,980 2,492 2,415 2,530 1,786
Total Current Assets
706 999 1,149 1,246 805
Cash & Equivalents
317 565 444 791 516
Short-Term Investments
94 103 325 180 73
Accounts Receivable
120 109 184 149 97
Inventories, net
32 34 32 29 17
Prepaid Expenses
47 57 61 45 37
Current Deferred & Refundable Income Taxes
43 89 58 27 27
Other Current Assets
48 28 33 21 -
Other Current Nonoperating Assets
4.44 14 12 0.30 13
Plant, Property, & Equipment, net
853 892 696 548 412
Plant, Property & Equipment, gross
853 892 696 548 412
Total Noncurrent Assets
379 447 427 735 570
Long-Term Investments
2.21 3.40 17 319 72
Intangible Assets
320 322 319 35 120
Noncurrent Deferred & Refundable Income Taxes
54 120 86 83 74
Other Noncurrent Operating Assets
3.59 0.93 4.05 6.81 1.12
Total Liabilities & Shareholders' Equity
1,980 2,492 2,415 2,530 1,786
Total Liabilities
498 547 579 954 896
Total Current Liabilities
357 514 361 367 255
Accounts Payable
89 149 104 82 52
Current Deferred & Payable Income Tax Liabilities
8.82 6.16 9.61 12 4.11
Other Current Liabilities
203 183 208 216 175
Total Noncurrent Liabilities
637 739 783 603 647
Noncurrent Deferred & Payable Income Tax Liabilities
15 20 20 20 25
Other Noncurrent Operating Liabilities
182 190 238 59 53
Total Equity & Noncontrolling Interests
986 1,239 1,270 1,559 885
Total Preferred & Common Equity
986 1,239 1,270 1,559 885
Total Common Equity
986 1,239 1,270 1,559 885
Common Stock
1,690 1,800 1,730 1,819 1,459
Retained Earnings
-696 -527 -420 -245 -529
Accumulated Other Comprehensive Income / (Loss)
-7.60 -34 -40 -14 -46

Quarterly Balance Sheets for Evotec

No quarterly balance sheets for Evotec are available.


Annual Metrics And Ratios for Evotec

This table displays calculated financial ratios and metrics derived from Evotec's official financial filings.

Metric 2024 2023 2022 2021 2020 2019
Period end date 12/31/2024 12/31/2023 12/31/2022 12/31/2021 12/31/2020 12/31/2019
Growth Metrics
- - - - - -
Revenue Growth
-4.57% 7.53% 14.93% 14.31% 22.14% 0.00%
EBITDA Growth
-209.62% -62.47% -1.85% -3.63% -4.88% 0.00%
EBIT Growth
-178.98% -257.42% -24.69% -25.24% -24.44% 0.00%
NOPAT Growth
-72.52% -335.61% -63.00% 409.02% -813.18% 0.00%
Net Income Growth
-118.65% 50.60% -177.04% 3,080.42% -81.68% 0.00%
EPS Growth
-121.00% 50.91% -171.98% 0.00% 0.00% 0.00%
Operating Cash Flow Growth
-109.17% 81.68% -498.15% -115.43% 268.44% 0.00%
Free Cash Flow Firm Growth
107.59% -713.00% -147.06% 98.47% 0.00% 0.00%
Invested Capital Growth
-7.45% 23.64% 5.44% 6.88% 0.00% 0.00%
Revenue Q/Q Growth
0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
EBITDA Q/Q Growth
0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
EBIT Q/Q Growth
0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
NOPAT Q/Q Growth
0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Net Income Q/Q Growth
0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
EPS Q/Q Growth
0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Operating Cash Flow Q/Q Growth
0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Free Cash Flow Firm Q/Q Growth
0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Invested Capital Q/Q Growth
0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Profitability Metrics
- - - - - -
Gross Margin
14.41% 22.40% 23.16% 24.52% 25.10% 29.77%
EBITDA Margin
-6.22% 5.41% 15.50% 18.15% 21.53% 27.65%
Operating Margin
-10.99% -6.08% 2.77% 6.63% -4.07% -0.42%
EBIT Margin
-18.97% -6.49% 4.43% 6.76% 10.34% 16.72%
Profit (Net Income) Margin
-24.60% -10.74% -23.38% 34.87% 1.25% 8.36%
Tax Burden Percent
101.08% 104.12% 114.09% 90.94% 14.49% 55.55%
Interest Burden Percent
128.33% 158.97% -462.32% 566.99% 83.66% 90.01%
Effective Tax Rate
0.00% 0.00% 0.00% 9.06% 45.14% 28.83%
Return on Invested Capital (ROIC)
-5.97% -3.68% 1.79% 5.14% -3.44% 0.00%
ROIC Less NNEP Spread (ROIC-NNEP)
280.65% 18.28% 39.20% -45.05% -49.80% 0.00%
Return on Net Nonoperating Assets (RNNOA)
-12.28% -3.72% -15.08% 14.81% 5.18% 0.00%
Return on Equity (ROE)
-18.25% -7.40% -13.28% 19.96% 1.73% 0.00%
Cash Return on Invested Capital (CROIC)
1.77% -24.82% -3.50% -1.51% -203.44% 0.00%
Operating Return on Assets (OROA)
-7.00% -2.29% 1.44% 2.19% 3.54% 0.00%
Return on Assets (ROA)
-9.08% -3.78% -7.60% 11.30% 0.43% 0.00%
Return on Common Equity (ROCE)
-18.25% -7.40% -13.28% 19.96% 1.73% 0.00%
Return on Equity Simple (ROE_SIMPLE)
-20.59% -7.49% -14.80% 15.64% 0.87% 0.00%
Net Operating Profit after Tax (NOPAT)
-63 -37 16 42 -14 -1.50
NOPAT Margin
-7.69% -4.26% 1.94% 6.03% -2.23% -0.30%
Net Nonoperating Expense Percent (NNEP)
-286.61% -21.96% -37.41% 50.20% 46.36% 0.00%
Return On Investment Capital (ROIC_SIMPLE)
-6.44% - - - - -
Cost of Revenue to Revenue
85.59% 77.60% 76.84% 75.48% 74.90% 70.23%
SG&A Expenses to Revenue
23.61% 21.71% 20.79% 17.06% 15.41% 14.88%
R&D to Revenue
6.38% 8.77% 10.20% 11.68% 12.77% 13.09%
Operating Expenses to Revenue
25.41% 28.48% 20.39% 17.89% 29.17% 30.19%
Earnings before Interest and Taxes (EBIT)
-156 -56 36 47 63 84
Earnings before Interest, Taxes, Depreciation and Amortization (EBITDA)
-51 47 125 127 132 139
Valuation Ratios
- - - - - -
Price to Book Value (P/BV)
0.37 0.84 0.56 0.30 1.02 0.00
Price to Tangible Book Value (P/TBV)
0.55 1.13 0.75 0.39 1.95 0.00
Price to Revenue (P/Rev)
0.45 1.20 0.89 0.68 1.48 2.05
Price to Earnings (P/E)
0.00 0.00 0.00 1.95 31.16 19.16
Dividend Yield
0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Earnings Yield
0.00% 0.00% 0.00% 51.35% 3.21% 5.22%
Enterprise Value to Invested Capital (EV/IC)
0.00 0.33 0.00 0.00 1.04 0.00
Enterprise Value to Revenue (EV/Rev)
0.00 0.42 0.00 0.00 1.35 0.00
Enterprise Value to EBITDA (EV/EBITDA)
0.00 7.83 0.00 0.00 6.28 0.00
Enterprise Value to EBIT (EV/EBIT)
0.00 0.00 0.00 0.00 13.07 0.00
Enterprise Value to NOPAT (EV/NOPAT)
0.00 0.00 0.00 0.00 0.00 0.00
Enterprise Value to Operating Cash Flow (EV/OCF)
0.00 0.00 0.00 0.00 4.74 0.00
Enterprise Value to Free Cash Flow (EV/FCFF)
0.00 0.00 0.00 0.00 0.00 0.00
Leverage & Solvency
- - - - - -
Debt to Equity
0.00 0.00 0.00 0.36 0.66 0.00
Long-Term Debt to Equity
0.00 0.00 0.00 0.34 0.64 0.00
Financial Leverage
-0.04 -0.20 -0.38 -0.33 -0.10 0.00
Leverage Ratio
2.01 1.96 1.75 1.77 2.02 0.00
Compound Leverage Factor
2.58 3.11 -8.08 10.01 1.69 0.00
Debt to Total Capital
0.00% 0.00% 0.00% 26.57% 39.72% 0.00%
Short-Term Debt to Total Capital
0.00% 0.00% 0.00% 1.93% 1.28% 0.00%
Long-Term Debt to Total Capital
0.00% 0.00% 0.00% 24.64% 38.44% 0.00%
Preferred Equity to Total Capital
0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Noncontrolling Interests to Total Capital
0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Common Equity to Total Capital
100.00% 100.00% 100.00% 73.43% 60.28% 0.00%
Debt to EBITDA
0.00 0.00 0.00 4.44 4.43 0.00
Net Debt to EBITDA
0.00 0.00 0.00 -5.72 -0.59 0.00
Long-Term Debt to EBITDA
0.00 0.00 0.00 4.12 4.28 0.00
Debt to NOPAT
0.00 0.00 0.00 13.37 -42.71 0.00
Net Debt to NOPAT
0.00 0.00 0.00 -17.21 5.69 0.00
Long-Term Debt to NOPAT
0.00 0.00 0.00 12.40 -41.33 0.00
Altman Z-Score
0.32 1.35 1.27 0.92 1.02 0.00
Noncontrolling Interest Sharing Ratio
0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Liquidity Ratios
- - - - - -
Current Ratio
1.98 1.94 3.18 3.39 3.16 0.00
Quick Ratio
1.49 1.51 2.64 3.05 2.75 0.00
Cash Flow Metrics
- - - - - -
Free Cash Flow to Firm (FCFF)
19 -248 -31 -12 -807 0.00
Operating Cash Flow to CapEx
-201.29% -1,242.06% -83.02% -20.00% 0.00% 132.32%
Free Cash Flow to Firm to Interest Expense
0.00 0.00 0.00 0.00 -78.01 0.00
Operating Cash Flow to Interest Expense
0.00 0.00 0.00 0.00 16.88 5.66
Operating Cash Flow Less CapEx to Interest Expense
0.00 0.00 0.00 0.00 16.88 1.38
Efficiency Ratios
- - - - - -
Asset Turnover
0.37 0.35 0.33 0.32 0.34 0.00
Accounts Receivable Turnover
7.20 5.91 4.82 5.69 6.34 0.00
Inventory Turnover
21.27 20.30 20.22 23.06 27.62 0.00
Fixed Asset Turnover
0.95 1.09 1.29 1.46 1.49 0.00
Accounts Payable Turnover
5.95 5.31 6.63 7.87 8.82 0.00
Days Sales Outstanding (DSO)
50.72 61.78 75.66 64.18 57.57 0.00
Days Inventory Outstanding (DIO)
17.16 17.98 18.05 15.83 13.22 0.00
Days Payable Outstanding (DPO)
61.36 68.74 55.02 46.37 41.39 0.00
Cash Conversion Cycle (CCC)
6.51 11.02 38.69 33.64 29.39 0.00
Capital & Investment Metrics
- - - - - -
Invested Capital
1,023 1,105 894 848 793 0.00
Invested Capital Turnover
0.78 0.87 0.92 0.85 1.54 0.00
Increase / (Decrease) in Invested Capital
-82 211 46 55 793 0.00
Enterprise Value (EV)
-44 366 -71 -251 827 0.00
Market Capitalization
369 1,038 714 475 905 1,028
Book Value per Share
$5.56 $7.00 $7.19 $9.37 $5.76 $0.00
Tangible Book Value per Share
$3.76 $5.18 $5.38 $7.41 $3.01 $0.00
Total Capital
986 1,239 1,270 2,123 1,468 0.00
Total Debt
0.00 0.00 0.00 564 583 0.00
Total Long-Term Debt
0.00 0.00 0.00 523 564 0.00
Net Debt
-413 -672 -786 -726 -78 0.00
Capital Expenditures (CapEx)
13 2.38 194 135 0.00 36
Debt-free, Cash-free Net Working Capital (DFCFNWC)
-62 -183 19 -52 -20 0.00
Debt-free Net Working Capital (DFNWC)
349 485 787 920 569 0.00
Net Working Capital (NWC)
349 485 787 879 550 0.00
Net Nonoperating Expense (NNE)
139 56 204 -202 -21 -43
Net Nonoperating Obligations (NNO)
37 -134 -376 -712 -92 0.00
Total Depreciation and Amortization (D&A)
105 103 89 80 68 55
Debt-free, Cash-free Net Working Capital to Revenue
-7.46% -21.18% 2.33% -7.39% -3.22% 0.00%
Debt-free Net Working Capital to Revenue
42.33% 56.13% 97.94% 131.48% 92.98% 0.00%
Net Working Capital to Revenue
42.33% 56.13% 97.94% 125.63% 89.91% 0.00%
Earnings Adjustments
- - - - - -
Adjusted Basic Earnings per Share
$0.00 $0.00 $0.00 $0.00 $0.00 $0.00
Adjusted Weighted Average Basic Shares Outstanding
177.55M 177.19M 176.95M 176.61M 0.00 0.00
Adjusted Diluted Earnings per Share
($2.30) ($1.04) $0.00 $0.00 $0.00 $0.00
Adjusted Weighted Average Diluted Shares Outstanding
177.55M 177.19M 176.95M 176.61M 0.00 0.00
Adjusted Basic & Diluted Earnings per Share
$0.00 $0.00 $0.00 $0.00 $0.00 $0.00
Adjusted Weighted Average Basic & Diluted Shares Outstanding
177.30M 176.92M 176.95M 166.41M 0.00 0.00
Normalized Net Operating Profit after Tax (NOPAT)
-63 -33 16 43 -14 -1.50
Normalized NOPAT Margin
-7.69% -3.81% 1.94% 6.13% -2.23% -0.30%
Pre Tax Income Margin
-24.34% -10.31% -20.49% 38.34% 8.65% 15.05%
Debt Service Ratios
- - - - - -
EBIT to Interest Expense
0.00 0.00 0.00 0.00 6.12 10.01
NOPAT to Interest Expense
0.00 0.00 0.00 0.00 -1.32 -0.18
EBIT Less CapEx to Interest Expense
0.00 0.00 0.00 0.00 6.12 5.73
NOPAT Less CapEx to Interest Expense
0.00 0.00 0.00 0.00 -1.32 -4.46
Payout Ratios
- - - - - -
Dividend Payout Ratio
0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Augmented Payout Ratio
0.00% 0.00% 0.00% 0.00% 0.00% 0.00%

Quarterly Metrics And Ratios for Evotec

No quarterly metrics and ratios for Evotec are available.


Frequently Asked Questions About Evotec's Financials

When does Evotec's fiscal year end?

According to the most recent income statement we have on file, Evotec's financial year ends in December. Their financial year 2024 ended on December 31, 2024.

How has Evotec's net income changed over the last 5 years?

Evotec's net income appears to be on an upward trend, with a most recent value of -$202.96 million in 2024, falling from $41.87 million in 2019. The previous period was -$92.82 million in 2023.

What is Evotec's operating income?
Evotec's total operating income in 2024 was -$90.67 million, based on the following breakdown:
  • Total Gross Profit: $118.91 million
  • Total Operating Expenses: $209.58 million
How has Evotec revenue changed over the last 5 years?

Over the last 5 years, Evotec's total revenue changed from $501.02 million in 2019 to $824.94 million in 2024, a change of 64.7%.

How much debt does Evotec have?

Evotec's total liabilities were at $498.25 million at the end of 2024, a 9.0% decrease from 2023, and a 44.4% decrease since 2020.

How much cash does Evotec have?

In the past 4 years, Evotec's cash and equivalents has ranged from $317.14 million in 2024 to $791.50 million in 2021, and is currently $317.14 million as of their latest financial filing in 2024.

How has Evotec's book value per share changed over the last 5 years?

Over the last 5 years, Evotec's book value per share changed from 0.00 in 2019 to 5.56 in 2024, a change of 556.5%.



This page (OTCMKTS:EVTCY) was last updated on 5/24/2025 by MarketBeat.com Staff
From Our Partners